446 related articles for article (PubMed ID: 29890736)
1. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN
Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.
Gallegos KM; Drusano GL; D Argenio DZ; Brown AN
J Infect Dis; 2016 Oct; 214(8):1192-7. PubMed ID: 27496974
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
Franco EJ; Pires de Mello CP; Brown AN
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
[TBL] [Abstract][Full Text] [Related]
4. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN
Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
Rattanaburee T; Junking M; Panya A; Sawasdee N; Songprakhon P; Suttitheptumrong A; Limjindaporn T; Haegeman G; Yenchitsomanus PT
Antiviral Res; 2015 Dec; 124():83-92. PubMed ID: 26542647
[TBL] [Abstract][Full Text] [Related]
7. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC
Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543
[TBL] [Abstract][Full Text] [Related]
8. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo.
Chang J; Schul W; Butters TD; Yip A; Liu B; Goh A; Lakshminarayana SB; Alonzi D; Reinkensmeier G; Pan X; Qu X; Weidner JM; Wang L; Yu W; Borune N; Kinch MA; Rayahin JE; Moriarty R; Xu X; Shi PY; Guo JT; Block TM
Antiviral Res; 2011 Jan; 89(1):26-34. PubMed ID: 21073903
[TBL] [Abstract][Full Text] [Related]
9. Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses.
Yu JS; Tseng CK; Lin CK; Hsu YC; Wu YH; Hsieh CL; Lee JC
Antiviral Res; 2017 Jan; 137():49-57. PubMed ID: 27847245
[TBL] [Abstract][Full Text] [Related]
10. Testing antiviral compounds in a dengue mouse model.
Schul W; Yip A; Shi PY
Methods Mol Biol; 2013; 1030():269-81. PubMed ID: 23821275
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.
Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of geraniin on dengue virus type-2 infected BALB/c mice.
Abdul Ahmad SA; Palanisamy UD; Khoo JJ; Dhanoa A; Syed Hassan S
Virol J; 2019 Feb; 16(1):26. PubMed ID: 30813954
[TBL] [Abstract][Full Text] [Related]
13. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3.
Vigani AG; Gonçales ES; Pavan MH; Genari F; Tozzo R; Lazarini MS; Fais V; Feltrin A; Gonçales NS; Gonçales FL
Braz J Infect Dis; 2012; 16(3):232-6. PubMed ID: 22729189
[TBL] [Abstract][Full Text] [Related]
15. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8.
Tokumoto Y; Hiasa Y; Uesugi K; Watanabe T; Mashiba T; Abe M; Kumagi T; Ikeda Y; Matsuura B; Onji M
J Infect Dis; 2012 Apr; 205(7):1121-30. PubMed ID: 22357660
[TBL] [Abstract][Full Text] [Related]
17. Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors.
Yeo KL; Chen YL; Xu HY; Dong H; Wang QY; Yokokawa F; Shi PY
Antimicrob Agents Chemother; 2015 Apr; 59(4):2086-93. PubMed ID: 25624323
[TBL] [Abstract][Full Text] [Related]
18. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection.
Pawlotsky JM; Flisiak R; Sarin SK; Rasenack J; Piratvisuth T; Chuang WL; Peng CY; Foster GR; Shah S; Wedemeyer H; Hézode C; Zhang W; Wong KA; Li B; Avila C; Naoumov NV;
Hepatology; 2015 Oct; 62(4):1013-23. PubMed ID: 26118427
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
20. Novel antiviral activity of bromocriptine against dengue virus replication.
Kato F; Ishida Y; Oishi S; Fujii N; Watanabe S; Vasudevan SG; Tajima S; Takasaki T; Suzuki Y; Ichiyama K; Yamamoto N; Yoshii K; Takashima I; Kobayashi T; Miura T; Igarashi T; Hishiki T
Antiviral Res; 2016 Jul; 131():141-7. PubMed ID: 27181378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
